Oscar Health Inc
OSCR
ISIN null / Valor 59901290
Oscar Health Inc
UMushroom community rating:
About company
Oscar Health Inc is a technology-driven health insurance company that has been innovating in the healthcare industry since its foundation in 2012. The company made its mark by offering individual health insurance plans starting in 2014, emphasizing the importance of accessible and efficient healthcare services. A notable aspect of its offerings includes 24/7 access to virtual care services, which underscores its commitment to leveraging technology to improve patient care and convenience. In 2020, Oscar Health expanded its services with the launch of its Virtual Primary Care, further enhancing its virtual healthcare solutions. The following year, in 2021, Oscar Health celebrated a significant milestone by going public with an Initial Public Offering (IPO) on the New York Stock Exchange (NYSE). Additionally, the company introduced +Oscar, a service aimed at broadening its market reach and service offerings, although specific details of this service were not provided. Oscar Health's approach to healthcare, focusing on innovation and accessibility, positions it as a notable player in the health insurance industry.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (07.10.2025):
Oscar Health Inc reported its full-year financial results for 2024, marking significant milestones as the company achieved both Adjusted EBITDA and net income profitability for the first time in its history. The strong top and bottom line performance, coupled with an all-time high in membership, underscores Oscar Health's ability to deliver sustained profitable growth.
Revenue Growth
Total revenue reached $9.2 billion, a 56.5% increase year-over-year, driven primarily by substantial membership growth during the 2024 Open Enrollment, strong retention rates, and additions during the Special Enrollment Period (SEP).
Profitability Milestones
Oscar achieved a net income attributable to the company of $25.4 million, or $0.10 per diluted share, marking a $296.2 million improvement year-over-year. Additionally, Adjusted EBITDA rose to $199.2 million, an increase of $244.5 million compared to the previous year.
Operational Efficiency
The Selling, General, and Administrative (SG&A) expense ratio significantly improved by 520 basis points to 19.1%, driven by enhanced fixed cost leverage and variable cost efficiencies.
Medical Loss Ratio
The Medical Loss Ratio increased by 10 basis points to 81.7%, mainly due to SEP membership growth and a rise in risk adjustment transfer, partially offset by favorable prior period development.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
3007 M
Market cap (USD)
11,354,743
Daily traded volume (Shares)
13.73 / 13.27
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Etienne Chen
EQUITIES OF THE SAME SECTOR
